glp-1 receptor agonists in idiopathic intracranial hypertension Recurrent Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema OnlineFirst: Impact of GLP-1 receptor
Description
What happens if you stop taking GLP-1 medications suddenly
Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer, semaglutide a potential treatment for serious weight gain from ALK tyrosine kinase inhibitors
Matthews DR, Li Q, Perkovic V, et al
RCTs evaluating GLP-1 RA have not identified indicators of suicidality
GLP-1R Agonist Therapy for Diabetes: Benefits and Potential Risks
